Medical News

RSS

NeoGenomics first-quarter revenue up 22%

NeoGenomics, Inc., a leading provider of cancer-focused genetic testing services today reported its results for the first quarter 2010.

29 Apr 2010

SDI reports increase in hospital outpatient surgical visits in 2009

SDI, a leading healthcare market insight and analytics firm, today reported that the number of hospital outpatient surgical visits increased 4.5% in 2009 compared with 2008. The number of hospital inpatient visits with surgical procedures, however, remained relatively unchanged in 2009.

29 Apr 2010

EMSC generates net revenue of $679.4 million for first-quarter 2010

Emergency Medical Services Corporation today announces results for the first quarter ended March 31, 2010.

29 Apr 2010

Orion Health Rhapsody Integration Engine to be deployed across Philips' healthcare informatics solutions

Royal Philips Electronics today announced an agreement with Orion Health™, a leading provider of integration solutions in healthcare, to deploy the Orion Health Rhapsody® Integration Engine across Philips' portfolio of healthcare informatics solutions.

From Philips Healthcare 29 Apr 2010

Nutraceutical International reports net sales of $47.9M for second-quarter fiscal 2010

Nutraceutical International Corporation today reported results for the fiscal 2010 second quarter ended March 31, 2010. Net sales for the fiscal 2010 second quarter were $47.9 million compared to $42.0 million for the same quarter of fiscal 2009. For the second quarter of fiscal 2010, net income was $5.1 million, or $0.49 diluted earnings per share, compared to a net loss of $(23.4) million, or $(2.15) per diluted share, for the same quarter of fiscal 2009.

29 Apr 2010

Investment report on Somaxon Pharmaceuticals from MicroStockProfit.com

MicroStockProfit.com announces an investment report featuring Somaxon Pharmaceuticals Inc. The report includes financial, comparative and investment analyses, and industry information you need to know to make an educated investment decision.

29 Apr 2010

Bruker reports 20.5% increase in revenue for first-quarter 2010

Bruker Corporation today reported financial results for the first quarter ended March 31, 2010.

29 Apr 2010

Natus Medical's revenue for first-quarter 2010 increased 47% to $49.2M

Natus Medical Incorporated today announced financial results for the three months ended March 31, 2010.

29 Apr 2010

Medtronic to acquire ATS Medical for $370M

Medtronic, Inc., and ATS Medical, Inc., today announced that the companies have signed a definitive agreement under which Medtronic will acquire ATS Medical by paying $4.00 per share in cash for each share of ATS Medical stock.

29 Apr 2010

HealthSpring's first-quarter premium revenue up 18.1% to $749.4 million

HealthSpring, Inc. today announced its results for the first quarter ended March 31, 2010.

29 Apr 2010

Labopharm, Gruppo Angelini sign agreement to commercialize OLEPTRO in the U.S.

Labopharm Inc. and Gruppo Angelini today announced they have entered into an agreement to establish a joint venture in the United States for the commercialization of OLEPTRO, a novel once-daily formulation of the antidepressant trazodone approved by the U.S. Food and Drug Administration on February 3, 2010.

29 Apr 2010

Celgene's first-quarter non-GAAP total revenue up 31% to $789 million

Celgene Corporation announced non-GAAP net income of $294.6 million, or non-GAAP diluted earnings per share of $0.63 for the quarter ended March 31, 2010. Non-GAAP net income for the first quarter of 2009 was $205.1 million or non-GAAP diluted earnings per share of $0.44. Based on U.S. GAAP, Celgene reported net income of $234.4 million, or diluted earnings per share of $0.50 for the quarter ended March 31, 2010. GAAP net income for the first quarter of 2009 was $162.9 million, or diluted earnings per share of $0.35.

29 Apr 2010

Caliper Life Sciences' first-quarter 2010 GAAP revenues increase 1% to $28.7M

Caliper Life Sciences, Inc., today reported its first quarter 2010 results.

29 Apr 2010

First Edition: April 29, 2010

This week, as yet another major health insurer reports quarterly gains, the industry says it will stop the practice of rescissions earlier than required by the new reform law. Meanwhile, other headlines examine key provisions of the measure, such as its high risk pools.

29 Apr 2010

6 transplant surgeons perform 16 surgeries over 3 days in landmark domino paired kidney exchange

Chicago resident Maria Isho had been waiting for over nine years for a kidney transplant. Her body was highly sensitized, meaning that her body had built up antibodies in the blood, which made it difficult for her to find a match. To stay healthy, she endured a grueling dialysis regimen which diminished her quality of life and left her feeling physically drained.

29 Apr 2010

Premier healthcare alliance launches strategic plan to support new models of healthcare delivery

The Premier healthcare alliance has launched a major new strategic plan that will help hospitals leverage performance improvement data and knowledge sharing to prepare for and succeed under healthcare reform.

29 Apr 2010

Research initiative to study impact of microbes on human health, disease

The human species is dependent for its survival on the billions of microorganisms that inhabit multiple environmental niches within and on the human body. While microbes are commonly associated with diseases and infections, they are also vital in essential, beneficial roles such as digestion, where they help synthesize vitamins and ferment complex indigestible carbohydrates.

29 Apr 2010

Provectus reports on end-of-Phase 2 meeting with FDA on licensure of PV-10 for metastatic melanoma

Provectus Pharmaceuticals, Inc., a development-stage oncology and dermatology biopharmaceutical company, announced today that it has held an end-of-Phase 2 meeting with the U.S. Food and Drug Administration (FDA) to seek consensus on clinical program scope and endpoints for licensure of PV-10 for metastatic melanoma. The meeting was held at the Agency's White Oak Campus in Silver Spring, MD.

29 Apr 2010

Study investigates efficacy of acellular dermal matrix for intestinal elongation

Acellular dermal matrix (ADM) is a dermal biomaterial in which all of the cellular elements have been removed. The biologic properties of ADM, including its ability to support tissue regeneration repopulation with fibroblasts, revascularization, new collagen deposition and eventual absorption and replacement with native tissue permit its use in tissue reconstruction.

29 Apr 2010

The OCD Project challenges six severe OCD sufferers to face fears in a bold move to better their lives

Obsessive-Compulsive Disorder is a disorder of the brain where people experience obsessive thoughts, images, ideas or impulses – and they can't get past them. The day-to-day existence for severe OCD sufferers is dire. Untreated, they lead lives of self-punishment, fear and isolation that can result in job loss, broken families, bankruptcy and in some cases death.

29 Apr 2010